major license and rd collaboration , page-2

I like this part:

Cytopia will receive payments from Novartis of
approximately A$13 million over three years including an up front payment and research
funding. Over the life of the agreement Cytopia may become eligible to receive
development, regulatory and sales milestones which could total approximately A$274
million if an agreed number of multiple indications are successfully commercialised.
Cytopia will also receive royalties on product sales.